ArticleAnnals of surgical oncology2026
Fluorescence-Guided Remnant-Sparing Laparoscopic Distal Pancreatectomy for Metachronous Pancreatic Cancer Following Whipple Procedure.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCompletion total pancreatectomy is the traditional approach for metachronous pancreatic cancer developing after pancreaticoduodenectomy (PD). However, this method causes significant morbidity and leads to pancreatogenic diabetes. While preserving the pancreatic remnant can maintain its function, it is technically demanding due to postoperative adhesions and altered anatomy. This video demonstrates a standardized laparoscopic approach for remnant-sparing distal pancreatectomy utilizing fluorescence guidance to ensure remnant perfusion.
methodsA 69-year-old female, 2.5 years post-laparoscopic PD for ampullary cancer, presented with rising CA 19-9 levels and a new well-differentiated adenocarcinoma in the pancreatic tail confirmed by EUS-FNA. We planned a laparoscopic distal pancreatectomy with splenectomy, preserving the prior pancreaticojejunostomy. The 5-port procedure employed a medial-to-lateral approach, dissecting along embryologic fascial planes (Toldt's fascia) to maintain oncologic principles.
resultsThe procedure lasted 123 min, with estimated blood loss of 20 mL. Postoperative recovery was uneventful; drain fluid amylase was normal (23 U/L) on postoperative Day 5, allowing for discharge. Final pathology confirmed a 3.7 cm pT2N0M0 (Stage IB) ductal adenocarcinoma with negative margins. At 6-month follow-up, the patient showed no recurrence and maintained stable endocrine and exocrine function.
conclusionsLaparoscopic remnant-sparing distal pancreatectomy is a feasible and safe oncologic approach for selected patients with metachronous cancer following PD. The combination of embryologic plane dissection and fluorescence imaging facilitates this complex reoperation, allowing for preservation of essential endocrine function without compromising oncologic principles.
Indexed as
Identifiers
42141338What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.